Goldman Sachs
EVLO

Goldman Sachs’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Goldman Sachs’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,285
Closed -$4.64K – 6211
2023
Q1 		$4.64K Sell
1,285
-282
-18% -$4.35K ﹤0.01% 5799
2022
Q4 		$50.5K Sell
1,567
-136
-8% -$5.38K ﹤0.01% 5597
2022
Q3 		$71K Sell
1,703
-399
-19% -$18.2K ﹤0.01% 5758
2022
Q2 		$89K Sell
2,102
-596
-22% -$27.6K ﹤0.01% 5898
2022
Q1 		$183K Buy
2,698
+205
+8% +$17.1K ﹤0.01% 5920
2021
Q4 		$302K Buy
2,493
+568
+30% +$95.9K ﹤0.01% 5665
2021
Q3 		$271K Buy
1,925
+586
+44% +$116K ﹤0.01% 5563
2021
Q2 		$368K Buy
1,339
+636
+90% +$160K ﹤0.01% 5396
2021
Q1 		$150K Buy
703
+142
+25% +$39.2K ﹤0.01% 5741
2020
Q4 		$136K Buy
561
+51
+10% +$6.31K ﹤0.01% 5229
2020
Q3 		$54K Buy
+510
New +$46.5K ﹤0.01% 5183
2019
Q3 		– Sell
-13,482
Closed -$2.42M – 5443
2019
Q2 		$2.42M Sell
13,482
-9
-0.1% -$1.46K ﹤0.01% 3404
2019
Q1 		$2.16M Sell
13,491
-786
-6% -$156K ﹤0.01% 3597
2018
Q4 		$3.71M Sell
14,277
-1,421
-9% -$286K ﹤0.01% 3126
2018
Q3 		$3.82M Sell
15,698
-1,140
-7% -$298K ﹤0.01% 3177
2018
Q2 		$3.97M Buy
+16,838
New +$4.91M ﹤0.01% 3119

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs's EVLO Position: Q2 2023 in Review

Goldman Sachs sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q2 2023, closing a stake of 1,285 shares — an estimated $4.64K sold.

Goldman Sachs first reported a position in EVLO in Q2 2018 and held it in 16 quarters. The position peaked at $3.97M in Q2 2018. 25 funds tracked by Wall St. Rank hold EVLO as of Q2 2023.

  • Goldman Sachs reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Goldman Sachs sold 1,285 Evelo Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $4.64K.
  • Goldman Sachs first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2018 and held it in 16 quarters.
  • Goldman Sachs's Evelo Biosciences, Inc. Common Stock position peaked at $3.97M in Q2 2018.
  • 25 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.